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Abstract
Background: Blastocystis sp. are among the most commonly observed intestinal parasites in routine clinical
parasitology. Blastocystis in humans consists of at least 9 genetic subtypes. Different subtypes of Blastocystis may be
associated with differences in pathogenicity and symptomatology.
Methods: Advanced microscopy on two samples and sequence-confirmed PCR on a third sample from the same
individual were used for Blastocystis diagnosis and subtype analyses on routine clinical samples in a university
hospital.
Results: With a combined gold standard of sequence-confirmed PCR and positive advanced microscopy, 107 out
of 442 (24.2%) patients were diagnosed with Blastocystis. infection, which is a high frequency of detection in
comparison to previous reports from industrialized countries. The sensitivity of microscopy and sequence-confirmed
PCR was 99.1% (106/107) and 96.3% (103/107), respectively.
Among 103 typable samples, subtype 3 was most abundant (n = 43, 42%), followed by subtypes 1 and 2 (both
n = 23, 22%), subtype 4 (n = 12, 12%), and single samples with subtypes 6 (1%) and subtype 7 (1%). The prevalence
of Blastocystis infection was 38% in patients from the Department of Tropical Medicine and 18% in patients from
other departments.
Conclusions: A high prevalence of Blastocystis infection was found with both advanced microscopy and sequence-
confirmed PCR in our patient population. Most cases were caused by subtypes ST1, ST2, ST3 and ST4. A significantly
higher prevalence was found among patients with a history of recent travel to tropical countries.
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Background
Blastocystis is one of the most prevalent unicellular para-
sites in human faecal specimens. The prevalence of
Blastocystis has been reported to range from 60% in
tropical, subtropical and developing countries [1] to as
low as 0.5% in Japan [2]. Considerable variation in
reported prevalence can be related to the epidemio-
logical setting, especially the patient population studied,
but is probably also due to differences in the diagnostic
methods used [3]. Transmission of Blastocystis is sug-
gested to be by the faecal-oral route, e.g. via contami-
nated water or food, with sources being both humans
and animals [4-6].
Clinical features of Blastocystis infection are reported
to include nausea, anorexia, abdominal pain, flatulence
and acute or chronic diarrhoea [7,8]. In addition, an as-
sociation is suggested with symptomatology in irritable
bowel syndrome [9-13] and, as an opportunistic patho-
gen, in immunocompromised patients [14,15]. Other
studies however suggest Blastocystis to be a commensal
parasite in humans without any pathogenic role [16-18].
Conflicting views about pathogenicity may be related
to the number of infecting parasites present, duration of
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infection (acute or chronic), host genetic factors or to
different subtypes or species of Blastocystis infecting
humans [3,19-27]. Currently 17 subtypes or species of
Blastocystis have been described based on sequence ana-
lysis, of which 9 have been reported in humans [28-31].
For proper study of prevalence, epidemiology and patho-
genic potential of Blastocystis, reliable and practical diag-
nosis is of paramount importance. Techniques currently in
use include microscopy, molecular detection, and xenic
in vitro culture [3]. Recent studies suggest certain molecu-
lar methods to have highest sensitivities [26,32-34]. In this
report we compare sequence-confirmed PCR to advanced
microscopy, and describe the prevalence of Blastocystis in-
fection and subtype determination in a large series of pa-
tients in The Netherlands.
Methods
Samples and parasitological examination
Stool samples of 442 patients submitted for routine para-
sitological examination at the Department of Clinical
Parasitology, Academic Medical Center (AMC) were col-
lected and processed with the Triple Faeces Test (TFT) as
described previously [35]. Microscopy with the TFT has
been part of routine clinical care in the AMC for 18 years.
In brief, with the TFT every patient fills three tubes with
stools on 3 consecutive days. Tubes of day 1 and day 3 are
prefilled with SAF (sodium acetate–acetic acid–formalin),
while the tube of day two is empty. After 3 days the
complete TFT set is sent to the laboratory by the patient.
Compliance of patients for proper delivery of the whole
set is high [35]. SAF-stool suspensions of days 1 and 3 are
studied in the laboratory by an iodine stained wet smear
and, in case of undetermined protozoa, by a permanent
Chlorazol Black stain [35]. Fresh (non-fixed) stool of day 2
is routinely processed by the formol ether concentration
technique (FECT) for diagnosis of (cysts and eggs of)
protozoa and helminths. In addition, on sample 2 auramine
stain for Cryptosporidium, Uvitex 2B for Microsporidia,
antigen tests and PCR are performed when indicated. In
this study PCR for Blastocystis was performed on sample 2.
For microscopic diagnosis of Blastocystis from each
SAF sample approximately 10 μl of SAF stool sample
was mixed with approximately 20 μl of Lugol’s iodine so-
lution and covered with a 21 × 26 mm cover slip. The
slide was examined for intestinal parasites, including
Blastocystis for 300 optical fields with a magnification
of 250× (20× objective and 12.5 eye piece) and, in case
of suspected organisms, 500 × (40 × 12.5×). Duration of
this examination per slide is 5 minutes on average. The
diagnostic criterion for positivity of Blastocystis species
was at least 2 clear vacuolar forms of the parasite in ei-
ther of the two SAF samples. Granular or amoeboid
stages of Blastocystis species were not studied.
Permanent staining with Chlorazol Black was routinely
performed on any SAF sample where further determin-
ation was needed, as is true for Dientamoeba fragilis and
other vegetative stages of protozoa. Results of iodine wet
smear and Chlorazol Black stain were compared on a se-
lected series of positive and negative samples. Techni-
cians performing microscopic diagnosis had extensive
experience in parasitological diagnosis and were blinded
for the results of PCR.
Molecular methods
All non-fixed stools collected on the second day were
mixed with Stool Transport and Recovery (S.T.A.R.)
Buffer (Roche Applied Science) to an approximately 1:3
v:v suspension and vortexed and stored for DNA isola-
tion and PCR. DNA was isolated from all faecal suspen-
sions using the MagNA Pure LC Isolation instrument
for nucleic acid extraction (Roche Applied Science). To
monitor the process of extraction and amplification, a
universal control consisting of phocine herpesvirus type
1 (PhHV-1) was added to the clinical specimens [36].
Briefly, 20 μl of faecal suspension was added to 500 μl
lysis buffer with 2500 copies PhHV-1 and prelysed for
10 minutes at room temperature. After centrifugation,
500 μl of the lysate supernatant was used as input for
the Total Nucleic Acid Isolation Kit (Roche Applied
Science) as described by the manufacturer. Elution of
nucleic acid was in a final volume of 50 μl. Blastocystis
PCR was performed using primers and conditions de-
scribed by Stensvold [33], aimed at a region of the small
subunit rRNA gene of Blastocystis, using 15 μl of iso-
lated DNA as input in a total volume of 50 μl. Fifteen
microliters of PCR product were size-separated by agarose
gel electrophoresis and visualized by UV illumination after
ethidium bromide staining. Diluted amplicons were se-
quenced on both strands using amplification primers with
BigDyeTerminator chemistry (Applied Biosystems) and
analysed on an ABI 3900 sequencer. Subtypes following
the nomenclature proposed by Stensvold et al [21] were
determined by comparison of obtained sequences to
Genbank reference sequences using CodonCode Aligner
program (CodonCode Corporation), and MEGA 4.0 [37].
For sequences that seemed to contain a mixed signal of
multiple subtypes, the predominant subtype was assigned.
Only samples for which a Blastocystis sequence was
obtained were considered PCR and sequencing positive.
Samples for which no Blastocystis sequence was obtained
or for which there was no PCR amplicon while the PhHV-
1 control DNA was detected using real-time PCR [36],
were considered negative. PCR and sequence interpret-
ation were performed blinded to the microscopy results.
Sequences were deposited in Genbank with accession
numbers KF241991-KF242090.
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Database and statistics
Samples and patient data (sex, age, referring depart-
ment) were anonymized and aggregated in a database.
For evaluation of diagnostic tests using anonymized
data no medical-ethical approval is required in The
Netherlands, provided that patients declare no objec-
tion to such use of their samples. Computations of
P values using Pearson’s χ2 test were performed at
VassarStats website (http://vassarstats.net/index.html).
P values below or equal to 0.05 were regarded as
significant.
Results
Study population and microscopy
From October 2008 to January 2009, 442 TFT sets from
442 patients were included in the study. The 442 patients
comprised 230 females (median age 29, range 1-82) and
212 males (median age 34, range 0-87 years). Patients were
referred by the Tropical Diseases Department (133),
Emma Children’s Hospital (103), general practicioners
(70), Department of Internal Medicine (63), Department
of Gastroenterology and Hepatology (45), or other depart-
ments (28).
In 148 out of 442 (33%) patients one or more intes-
tinal parasitic species were observed. Protozoa were ob-
served in 148 out of 442 (33%) and helminths in 3 out of
442 (0.7%) patients.
Blastocystis were recognized in either of the two SAF
preserved samples by microscopy of iodine stained wet
smears in 106 out of 442 (24.0%) patients in any of two
samples. In 90 patients, both SAF samples (day 1 and
day 3) were positive for Blastocystis. In 10 patients
Blastocystis was observed only in the sample of the first
day, and in 6 only in the sample of the third day. From
106 patients positive for Blastocystis with iodine wet
smear, 34 times a permanent Chlorazol Black stain was
performed for determination of other protozoa. In all
cases Blastocystis were also observed with the Chlorazol
Black stain. From 336 patients negative for Blastocystis
with iodine wet smear, 81 times a permanent stained
slide also was studied. In none of these Blastocystis was
observed.
PCR and Blastocystis subtype determination
In 103 out of 442 (23.3%) patients, sequence-confirmed
PCR was positive. Six subtypes were observed among
the 103 typable samples: subtype 3 was most abundant
(n = 43, 41%), followed by subtypes 1 and 2 (both n = 23,
22%), subtype 4 (n = 12, 12%), and single samples with
subtypes 6 (1%) and subtype 7 (1%) (Table 1).
Gold standard, congruence between microscopy and PCR
Assuming 100% specificity of both microscopy and
sequence-confirmed PCR, positive findings of both tests
were combined to serve as a gold standard. Using this
standard, 107 of 442 patients (24.2%) were positive for
Blastocystis. Microscopy, with reading of two SAF samples
studied per patient, had a sensitivity of 99.1% (106/107).
Sequence-confirmed PCR, performed on stool of the day
2 sample only, had a sensitivity of 96.3% (103/107).
In five samples, microscopy and sequence-confirmed
PCR were not in agreement. This concerned 4 times a
microscopy positive and sequence-PCR negative result,
and one sequence- PCR positive and microscopy nega-
tive result. All five samples were retested with both
methods. The four microscopically positive samples that
were PCR and sequence negative, were all positive for the
PhHV-1 extraction and amplification control, suggesting
that PCR was not negative due to insufficient DNA extrac-
tion or inhibitory factors in the eluate, but due to the
amount of Blastocystis DNA being below detection level.
This is in accordance with the observation of only few par-
asites (<5 per total slide) in two of these samples by mi-
croscopy. In the other two samples, more Blastocystis cells
were observed. By agarose gel electrophoresis of PCR
products, faint bands were visible in these samples. Appar-
ently, the yield of PCR amplicon was insufficient to obtain
good sequences in these two samples. Alternatively, the
microscopical observations may be explained by structures
that are morphologically highly similar to Blastocystis. In
the one sample that was PCR and sequencing positive, but
negative in microscopy, a weak band was observed in PCR
that yielded a sequence. Possibly, only Blastocystis DNA
or cysts were present in this sample, rather than intact
Blastocystis cells.
Table 1 Blastocystis infection status of patients admitted via the Department of Tropical Medicine and patients
admitted via other departments




ST1 ST2 ST3 ST4 Other ST NSTa
Submitted via dept tropical diseases 133 50 (38%)b 13 (26%) 10 (20%)c 20 (40%) 5 (10%) 1 (2%) 1 (2%)
Submitted via other departments 309 57 (18%)b 10 (18%) 13 (23%) 23 (40%) 7 (12%) 1 (2%) 3 (5%)
Total population 442 107 (31%) 23 (21%) 23 (21%) 43 (40%) 12 (11%) 2 (2%) 4 (4%)
a NST: not subtypable. These isolates were positive by microscopy only.
b p < 0.0001.
c one of these patients was negative by microscopy.
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Relation between Blastocystis infection, subtype and
patient characteristics
In the patient population from the Department of Trop-
ical Medicine, significantly (p < 0.0001; Pearson’s χ2 test)
more Blastocystis infection was found (38%, 50/133) as
compared to patients from other departments (18%, 57/
309), as shown in Table 1. There was no significant dif-
ference in the subtype distribution between patients pre-
senting at the Department of Tropical Medicine and
patients presenting at other departments.
No significant correlation between patient gender
and Blastocystis infection was found. Patients with
Blastocystis infection were more frequently coinfected
with Dientamoeba fragilis (17%, 18/107) than patients
without Blastocystis infection (8%, 26/335) (p < 0.006;
Pearson’s χ2 test). No significant correlation of the sub-
type of Blastocystis and Dientamoeba infection was
observed.
Discussion
In our hospital-derived study population, 24% (107/
442) of patients were infected with Blastocystis. This
is comparable to the reported 23% prevalence found
in a smaller (n = 93 patients) hospital population in
Denmark with direct PCR on stool samples [33], and
higher than 19% reported in Australia where a combin-
ation of microscopy, culture and PCR was used for
diagnosis [32]. In similar teaching hospital settings in
Italy [38] and the UK [39] considerably lower (7%)
prevalence was observed using microscopical methods
on one unfixed stool specimen for diagnosis. The
higher prevalence in our study can be due to selection
of our hospital population, assuming pathogenicity of
Blastocystis, but also to improved sensitivity of the
diagnostic procedures used.
The high prevalence in our population was observed
both by sequence-confirmed PCR and by microscopy.
With excellent specificity of both methods, the preva-
lence observed most likely represents the true occur-
rence of the parasite in our population. The high
sensitivity of microscopy was remarkable compared to
previous studies [32,39,40]. This can be explained by the
use of two fixed samples in the Triple Faeces Test rather
than single or fresh (non-preserved) samples as used in
previous studies [38,39]. In our study, microscopy on
two stool samples, compared to one sample, increased
the sensitivity of microscopy up to 10%. This is in agree-
ment with earlier reports where intermittent shedding of
Blastocystis was observed and stresses the need for mul-
tiple stool examinations with microscopy before reporting
a negative result [41,42]. Moreover, with the Triple Faeces
Test patients themselves add stool samples immediately
after defaecation to SAF fixative, reducing the time to fix-
ation to a minimum. This is in contrast to earlier reports
where stools were added to a fixative only after delivery in
the laboratory [32]. In fresh samples, vegetative stages of
protozoa, including Blastocystis, may rapidly deteriorate
and become microscopically unrecognizable [43]. Timely
fixation therefore is important for high diagnostic sensitiv-
ity of Blastocystis with microscopy.
Although microscopy on two samples proved very
effective for diagnosis of Blastocystis, equal results
with PCR diagnosis were obtained with examination
of one sample only. In addition, determination of the
subtype can be obtained, which is not possible by mi-
croscopy. We included sequence confirmation as a
criterion for a positive PCR, to assure 100% specifi-
city. Sequence-confirmed PCR was positive in 103 out
of 107 (97%) positive patients. Discrepancies between
sequence-confirmed PCR and microscopy in our
study probably were related to very low numbers of
Blastocystis shedded in the stools, resulting in insuffi-
cient amounts of PCR product to obtain a sequence.
The subtype distribution in the study population
showed six different subtypes: ST1, ST2, ST3, ST4,
ST6 and ST7. Subtypes 1-4 have been found as the
most common subtypes in previous studies as well,
[19,22,44-49], including molecular studies using sam-
ples initially cultured in vitro. Various studies have
identified ST3 as the predominant subtype, as was
true for our study population. Subtype 4 was rela-
tively frequent in our study group (12%) as compared
to studies worldwide [50], although a more similar
prevalence of this subtype was observed in studies
from Europe [25]. The differences in relative abun-
dance of the subtypes 1-4 suggests that differences in
transmission efficiency may exist between them.
These could include differences in cyst numbers, cyst
survival, exposure to cysts, infectious dose or trans-
mission cycles. The single subtype 6 and subtype 7
cases may reflect zoonotic infections, as these sub-
types have been reported in stools from birds [51,52].
The significantly higher prevalence of Blastocystis infec-
tion in patients presenting at the Department of Tropical
Medicine as compared to other departments, suggests that
travel to tropical countries can increase the risk of
Blastocystis infection, as has been observed in earlier stud-
ies [7,8,53,54]. High prevalence of Blastocystis has been
reported in developing countries [1,44,55,56]. Despite the
higher prevalence, the Blastocystis subtype distribution
among travelers and patients of other clinical departments
was similar. This suggests that general poor hygiene and
sanitation in many of the tropical countries rather than
specific exposure to certain Blastocystis subtypes, causes
the observed increase in prevalence. Unfortunately, no spe-
cific data about previous travel to tropical countries were
available for the patients from departments other than the
Department of Tropical Medicine.
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Conclusions
In conclusion, fast and reliable diagnosis of Blastocystis
infection in routine clinical parasitology is possible by
advanced microscopy on multiple fixed stool samples
with immediate fixation after production of stools. In
terms of sensitivity, specificity and subtype determin-
ation, direct PCR on a single stool sample is also an ex-
cellent diagnostic tool. The prevalence of Blastocystis
infection and the ongoing debate about pathogenicity
warrant the use of good diagnostic methods in routine
clinical laboratories. Other subjects of interest are pa-
tients with gastrointestinal complaints returning from
the tropics without pathogenic microorganisms but only
Blastocystis in stools. Further studies on pathogenicity,
and especially the importance of subtypes of Blastocystis,
are needed, as well as identification of an effective treat-
ment. For many of these studies excellent laboratory
diagnosis is a prerequisite.
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